On this page · 5 sections→
Where the EU money came from
Funding by EU programme. Amounts are Istituto Oncologico Veneto's own share of each project, not the project's full budget.
- FP7 (2007 to 2013)€1.3M · 3 projects
- EU4Health Programme (EU4H)€541k · 4 projects
- Horizon Europe€46k · 2 projects
- Euratom Research and Training Programme (EURATOM)€46k · 1 project
- Horizon 2020€0 · 1 project
Projects
11 EU-funded projects, newest first. Each links to the official record.
- AURORadAssociated partner
Advancing Unified Roadmap on implementation of the strategic agenda for medical ionising Radiation applications
EU4Health Programme (EU4H) · 2026–2031 · Project on the EU portal ↗
€230ktheir share - JANE-2Associated partner
Joint Action on Networks of Expertise on Cancer
EU4Health Programme (EU4H) · 2024–2028 · Project on the EU portal ↗
€183ktheir share - EUnetCCC JAAssociated partner
The European Comprehensive Cancer Centre Network
EU4Health Programme (EU4H) · 2024–2028 · Project on the EU portal ↗
€113ktheir share - DEFINITIVEAssociated partner
Diagnostic HER2DX-guided treatment for patients with early-stage HER2-positive breast cancer
Horizon Europe · 2023–2028 · Project on CORDIS ↗
- JANEAssociated partner
Joint Action on Networks of Expertise
EU4Health Programme (EU4H) · 2022–2024 · Project on the EU portal ↗
€15ktheir share - PIANOFORTEAssociated partner
Partnership for european research in radiation protection and detection of ionising radiation : towards a safer use and improved protection of the environment and human health.
Horizon Europe · 2022–2029 · Project on CORDIS ↗
€46ktheir share - PIANOFORTEAssociated partner
Partnership for european research in radiation protection and detection of ionising radiation : towards a safer use and improved protection of the environment and human health.
Euratom Research and Training Programme (EURATOM) · 2022–2029 · Project on the EU portal ↗
€46ktheir share - RealHOPEPartner
Real World Handling of Protein Drugs - Exploration, Evaluation and Education
Horizon 2020 · 2021–2025 · Project on CORDIS ↗
- CANCER-IDPartner
Cancer treatment and monitoring through identification of circulating tumour cells and tumour related nucleic acids in blood
FP7 (2007 to 2013) · 2015–2019 · Project on CORDIS ↗
€319ktheir share - CTCTRAPPartner
Circulating Tumor Cells TheRapeutic APheresis: a novel biotechnology enabling personalized therapy for all cancer patients
FP7 (2007 to 2013) · 2012–2016 · Project on CORDIS ↗
€636ktheir share - TRANS-INTPartner
New Oral Nanomedicines: Transporting Therapeutic Macromolecules across the Intestinal Barrier
FP7 (2007 to 2013) · 2012–2017 · Project on CORDIS ↗
€301ktheir share
Works most with
Organisations that shared the most EU projects with this one. A good starting list for consortium partners.
- Academisch Ziekenhuis GroningenNetherlands · 6 shared projects
- Deutsches Krebsforschungszentrum HeidelbergGermany · 6 shared projects
- Universiteit GentBelgium · 5 shared projects
- Institut Gustave RoussyFrance · 5 shared projects
- Institut Catala D'OncologiaSpain · 5 shared projects
- Nemzeti Nepegeszsegugyi Es Gyogyszereszeti KozpontHungary · 5 shared projects
- Katholieke Universiteit LeuvenBelgium · 4 shared projects
- Studiecentrum Voor Kernenergie / Centre D'Etude de L'Energie NucleaireBelgium · 4 shared projects
- Fundacio de Recerca Clinic Barcelona-Institut D Investigacions Biomediques August Pi i SunyerSpain · 4 shared projects
- Oslo Universitetssykehus HfNorway · 4 shared projects
- Fundacio Privada Institut D'Investigacio Oncologica de Vall-Hebron (Vhio)Spain · 4 shared projects
- Fondazione Irccs Istituto Nazionale Dei TumoriItaly · 4 shared projects
- Ministerio da SaudePortugal · 4 shared projects
- Hus-YhtymaFinland · 4 shared projects
- UnicancerFrance · 4 shared projects
- Office of the Deputy Prime Minister and Ministry for HealthMalta · 4 shared projects
Fields it works in
Research fields recorded on its Horizon projects.
- breast cancer
- carbohydrates
- drug resistance
- employment
- genetics
- lipids
- lung cancer
- metalloids
- nano-materials
- nanomedicine
- nucleic acids
- oncology
- personalized medicine
- pharmaceutical drugs
Is this your organisation?
Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.
Claim this profile →Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗
